Global Anticoagulant Reversal Drugs Market Size & Outlook
Global anticoagulant reversal drugs market, 2018-2030 (US$M)
Related Markets
Global anticoagulant reversal drugs market highlights
- The global anticoagulant reversal drugs market generated a revenue of USD 1,382.0 million in 2024 and is expected to reach USD 2,777.9 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 12.3% by 2030.
- In terms of segment, idarucizumab accounted for a revenue of USD 575.1 million in 2024.
- Andexanet Alfa is the most lucrative product type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 1,382.0 million |
| Market revenue in 2030 | USD 2,777.9 million |
| Growth rate | 12.3% (CAGR from 2025 to 2030) |
| Largest segment | Idarucizumab |
| Fastest growing segment | Andexanet Alfa |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Prothrombin Complex Concentrates, Phytonadione (Vitamin K), Andexanet Alfa, Idarucizumab, Protamine |
Other key industry trends
- In terms of revenue, the North America accounted for 38.6% of the global anticoagulant reversal drugs market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, China is the fastest growing regional market and is projected to reach USD 194.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Anticoagulant Reversal Drugs Market Scope
Anticoagulant Reversal Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Alps Pharmaceutical Industry Co | View profile | 251-500 | Hida, Gifu, Japan, Asia | http://www.alps-pharm.co.jp/ |
| SGPharma | View profile | 11-50 | Mumbai, Maharashtra, India, Asia | https://www.sgpharma.com |
| AMAG Pharmaceuticals | View profile | 251-500 | Lexington, Massachusetts, United States, North America | http://www.amagpharma.com |
| Octapharma AG | View profile | 10001+ | Lachen, Schwyz, Switzerland, Europe | http://www.octapharma.com/en.html |
| Bausch Health Companies Inc | View profile | 20270 | 2150 Saint Elzear Boulvard West, Laval, QC, Canada, H7L 4A8 | https://www.bauschhealth.com |
| CSL Ltd | View profile | 32000 | 655 Elizabeth Street, Melbourne, VIC, Australia, 3000 | https://www.csl.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Fresenius SE & Co KGaA | View profile | 193865 | Else-Kroener-Strasse 1, Bad Homburg, HE, Germany, 61352 | https://www.fresenius.com |
| Dr Reddy's Laboratories Ltd ADR | View profile | 22822 | 8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, India, 500 034 | https://www.drreddys.com |
Global anticoagulant reversal drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anticoagulant reversal drugs market will help companies and investors design strategic landscapes.
Idarucizumab was the largest segment with a revenue share of 41.61% in 2024. Horizon Databook has segmented the Global anticoagulant reversal drugs market based on prothrombin complex concentrates, phytonadione (vitamin k), andexanet alfa, idarucizumab, protamine covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Anticoagulant Reversal Drugs Product type Outlook (Revenue, USD Million, 2018-2030)
- Andexanet Alfa
- Idarucizumab
- Others
- Prothrombin Complex Concentrates
- Phytonadione (Vitamin K)
- Protamine
- Global Anticoagulant Reversal Drugs Distribution channel Outlook (Revenue, USD Million, 2018-2030)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Reasons to subscribe to Global anticoagulant reversal drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global anticoagulant reversal drugs market databook
-
Our clientele includes a mix of anticoagulant reversal drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global anticoagulant reversal drugs market, including forecasts for subscribers. This global databook contains high-level insights into Global anticoagulant reversal drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global anticoagulant reversal drugs market size, by regions, 2018-2030 (US$M)
Top 10 countries: Anticoagulant reversal drugs market size, 2024 (US$M)
Global anticoagulant reversal drugs market share, by product type, 2024 & 2030 (%, US$M)
Anticoagulant reversal drugs market: Opportunity assessment by country
Global anticoagulant reversal drugs market, by region, 2024 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
